White House Eyes Ophthalmologist Roberts For FDA; Frist Is Sponsor
This article was originally published in The Tan Sheet
Executive Summary
White House interest in Cornell ophthalmologist Calvin Roberts, MD, indicates that the search for a permanent FDA commissioner is continuing
You may also be interested in...
FDA Management Hierarchy Under Crawford Takes Shape; Alderson Elevated
The appointment of Center for Veterinary Medicine Office of Research Director Norris Alderson, PhD, as senior associate commissioner for science indicates that acting Commissioner Lester Crawford, PhD, is preparing for a prolonged tenure as head of FDA
FDA Commissioner Search: Wyeth’s Burlington Gets Renewed Consideration
Wyeth exec and former FDA Center for Devices & Radiological Health Director Bruce Burlington, MD, is again under consideration to take over the top position at the agency
PDUFA III Deal Includes Risk Management Fees In “Peri-Approval” Phase
The FDA/industry PDUFA III agreement includes funding to expand FDA's Office of Drug Safety by 100 full-time equivalent staff positions over five years